Sc. Olson et al., ANG-II STIMULATES ENDOTHELIAL NITRIC-OXIDE SYNTHASE EXPRESSION IN BOVINE PULMONARY-ARTERY ENDOTHELIUM, American journal of physiology. Lung cellular and molecular physiology, 17(2), 1997, pp. 315-321
Although angiotensin II (ANG II) is a known pulmonary vasoconstrictor,
the purpose of this study was to examine the effect of ANG II on pulm
onary artery endothelial cell nitric oxide synthase (ecNOS) mRNA and p
rotein expression. Cultured bovine pulmonary artery endothelial (BPAE;
passages 5-8) cells were incubated for 0-12 h with 10(-6) M ANG II. T
otal RNA was extracted, and ecNOS expression was assessed by Northern
blot analysis. In BPAE cells, ecNOS mRNA was significantly increased 2
.4 +/- 0.3-fold (P < 0.05 vs. basal; n = 5) 6 h after the addition of
ANG II over basal levels. In a similar time course, it was found that
ecNOS protein concentrations are increased 247 +/- 62% (P < 0.05 vs. b
asal; n = 8) over basal levels 4 h after ANG II addition. There is a s
econd protein peak 8 h after ANG II addition in which ecNOS was increa
sed 333 +/- 145% over basal (P < 0.05, n = 3). These data suggest that
ANG II stimulates ecNOS mRNA expression and are followed by increased
levels of ecNOS protein in cultured BPAE cells, consistent with an ob
served increase in nitrite production. Both the increase in ecNOS prot
ein and mRNA expression could be inhibited with the ANG II receptor an
tagonist saralasin. Additionally, actinomycin D, an inhibitor of trans
cription, prevented the rise in mRNA at 6 h while cycloheximide inhibi
ted the initial protein peak. The effects of ANG II on ecNOS were spec
ific for the pulmonary artery endothelium. Addition of ANG II did not
increase ecNOS protein or mRNA expression in parallel studies in bovin
e coronary artery endothelium. The stimulation of ecNOS by ANG II may
act to protect the lung and maintain low pulmonary artery pressures in
the renin-agiotensin model of systemic hypertension.